A Single Center, Randomized, Open Label, Single Dose, Two-Period, Crossover Phase I Study to Evaluate the Effect of Food (high-fat/standard Meal) on the Pharmacokinetics of SIM0270 in Healthy Adult Subjects in China
Latest Information Update: 04 Dec 2024
At a glance
- Drugs SCR-6852 (Primary)
- Indications Brain metastases; Breast cancer
- Focus Pharmacokinetics
- Sponsors Jiangsu Simcere Pharmaceutical
Most Recent Events
- 02 Dec 2024 Status changed from recruiting to completed.
- 06 Aug 2024 New trial record